ANDA 219773, held by Mankind Pharma. Phenytoin Sodium.
As of Nov 16, 2026, ANDA 219773 (Extended Phenytoin Sodium), held by Mankind Pharma, was first approved by FDA on Jan 2, 2026, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 2, 2026 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Extended Phenytoin Sodium100MG EXTENDED ยท capsule;oral | Phenytoin Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters